IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
From the first launch to ongoing market access execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We are the data and application backbone for market access departments of Life Sciences manufacturers, enabling them to accelerate their commercialization process, digitalize their operations, and get therapies to patients faster.
Solutions overview
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Keep in touch with IntegrChain through our news and frequent events.
View all news & events
Business Type
Division of Top-10 pharmaceutical manufacturer
Functional Area
Pricing Policy and Analytics for Managed Care
Challenge
Historically, Managed Care pricing decisions were made based on highly subjective information and emotion, not “fact based” on historic customer and contract performance. This was due in part to data that was so limited and inaccurate that often the customer was contacted to “see how are we doing.” As a result, members of the Pricing Committee realized that this environment was leading to substantial inefficiencies and marginal rebate investments with its managed care customers. We were brought in to help integrate managed care data and optimize rebate investments.
Business Challenges
Solution
We helped the manufacturer analyze approximately two years of data for its dominant brand, comprising more than 12 strategic PBMs and/or HMOs within the managed care market. Our team was supplied with imperfect internal data from the Excel worksheets and manually loaded it into our business tool. Analysis of third-party claims data served as a second validation that there were changes that needed to be made. Once the business parameters were defined, key accounts were then prioritized based on business variables, not emotion.
Results
By implementing our Rational Pricing methodology, the manufacturer was able to identify accounts that were underperforming from a market share and rebate investment perspective. We also developed best practice structures for the manufacturer resulting in a more manageable, efficient contact decision-making process.
Key Takeaways